Minor histocompatibility antigens as determinants for graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

被引:11
|
作者
Turpeinen, H. [1 ]
Ojala, P. J. [1 ]
Ojala, K. [2 ]
Miettinen, M. [1 ]
Volin, L. [3 ]
Partanen, J. [1 ]
机构
[1] Finnish Red Cross Blood Serv, Helsinki 00310, Finland
[2] Univ Helsinki, FIMM Inst Mol Med Finland, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Med, Div Haematol, Helsinki, Finland
关键词
RISK-ASSESSMENT; ACUTE GVHD; DISPARITY; RELEVANCE; MISMATCH; HA-1;
D O I
10.1111/iji.12051
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Minor histocompatibility antigens (minor H antigens) are genetically polymorphic peptides that have been shown to elicit immune response when mismatched between donor and recipient of haematopoietic stem cell transplantation (HSCT). Depending on the expression profiles, mismatches in these genes may either lead to harmful graft-versus-host (GvH) reaction or desired graft-versus-leukaemia (GvL) effect. We analysed retrospectively the effect of HLA-restricted matching 11 established autosomal minor H antigens on the risk of graft-versus-host disease and relapse in 311 HLA-matched sibling HSCT of a single centre. Increased incidence of chronic GvH disease was shown to be associated with mismatches in the HA-8 and ACC-1. The mRNA expression profiles in a large set of healthy and malignant tissue samples of minor H antigen genes demonstrated in silico that the expression profiles of HA-8 and ACC-1 were surprisingly different: HA-8 gene was expressed in practically all tissues, whereas ACC-1 gene had a restricted profile. The results demonstrated that mismatches in minor H antigens HA-8 and ACC-1 predisposed to chronic graft-versus-host disease (GvHD).
引用
收藏
页码:495 / 501
页数:7
相关论文
共 50 条
  • [41] IMPACT OF MISMATCHING FOR MINOR HISTOCOMPATIBILITY ANTIGENS ON THE OCCURRENCE OF GRAFT-VERSUS-HOST DISEASE
    GOULMY, E
    BLOKLAND, E
    GRATAMA, JW
    ZWAAN, FE
    VOSSEN, JMJJ
    SPECK, B
    VANROOD, JJ
    EXPERIMENTAL HEMATOLOGY, 1985, 13 : 127 - 127
  • [42] IMMUNODOMINANCE IN THE T-CELL GRAFT-VERSUS-HOST DISEASE RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS
    KORNGOLD, R
    WETTSTEIN, PJ
    FASEB JOURNAL, 1991, 5 (05): : A972 - A972
  • [43] Deciphering the role of Minor histocompatibility antigens for acute graft-versus-host disease
    Giesler, Sophie
    Zeiser, Robert
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (07): : 523 - 524
  • [44] Minor histocompatibility antigens and outcome after allogeneic stem cell transplantation
    Kircher, B
    Haun, M
    Lindner, B
    Nachbaur, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S80 - S80
  • [45] Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation
    Mohty, Mohamad
    LEUKEMIA & LYMPHOMA, 2007, 48 (09) : 1696 - 1701
  • [46] Microparticles for Diagnosis of Graft-Versus-Host Disease After Allogeneic Stem Transplantation
    Rank, Andreas
    Nieuwland, Rienk
    Toth, Bettina
    Pihusch, Verena
    Delker, Ruth
    Hiller, Erhard
    Kolb, Hans-Jochem
    Pihusch, Rudolf
    TRANSPLANTATION, 2011, 92 (02) : 244 - 250
  • [47] Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Nassar, Amr
    Elgohary, Ghada
    Elhassan, Tusneem
    Nurgat, Zubeir
    Mohamed, Said Y.
    Aljurf, Mahmoud
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [48] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [49] Serum catalase to predict graft-versus-host disease after allogeneic stem cell transplantation
    Kircher, B.
    Schumacher, P.
    Clausen, J.
    Auberger, J.
    Nachbaur, D.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S118 - S118
  • [50] Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation
    Quellmann, Susanne
    Schwarzer, Guido
    Huebel, Kai
    Greb, Alexander
    Engert, Andreas
    Bohlius, Julia
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (03):